chr7-150474047-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_175571.4(GIMAP8):c.718G>A(p.Glu240Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000601 in 1,613,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_175571.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GIMAP8 | NM_175571.4 | c.718G>A | p.Glu240Lys | missense_variant | 4/5 | ENST00000307271.4 | |
GIMAP8 | XM_005249950.5 | c.718G>A | p.Glu240Lys | missense_variant | 5/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GIMAP8 | ENST00000307271.4 | c.718G>A | p.Glu240Lys | missense_variant | 4/5 | 1 | NM_175571.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152134Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251344Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135834
GnomAD4 exome AF: 0.0000575 AC: 84AN: 1461790Hom.: 0 Cov.: 32 AF XY: 0.0000619 AC XY: 45AN XY: 727198
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152134Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.718G>A (p.E240K) alteration is located in exon 4 (coding exon 3) of the GIMAP8 gene. This alteration results from a G to A substitution at nucleotide position 718, causing the glutamic acid (E) at amino acid position 240 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at